Teva has received US Food and Drug Administration (FDA) approval for its ProAir Digihaler (albuterol sulfate) 117μg inhalation powder device, “the first and only digital inhaler with built-in sensors which connects to a companion mobile application and provides inhaler-use information to people with asthma and chronic obstructive pulmonary disease (COPD)”.
The prescription medicine is used to treat or prevent bronchospasm in patients with reversible obstructive airway disease and to prevent...



